AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio March 14, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Spain's Ferrovial to buy 24% stake in IRB Infrastructure Trust for $810 million Back: All Posts Next:Deliveroo beats earnings guidance, sees positive cash flow in 2024